"Salem Health Cancer Institute, located in Building C, is the collaborative alliance bringing the many providers, practices, and services across the continuum of cancer care together to provide the best possible experience and outcome for our patients and their families."

During the past decade, Salem Hospital Regional Cancer Care Services conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 11 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Salem Hospital Regional Cancer Care Services" #1 sponsor was "SWOG Cancer Research Network" with 15 trials, followed by "NSABP Foundation Inc" with 4 trials sponsored, "Radiation Therapy Oncology Group" with 4 trials sponsored, "Alliance for Clinical Trials in Oncology" with 3 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 3 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Salem Hospital Regional Cancer Care Services" #1 collaborator was "National Cancer Institute (NCI)" with 27 trials as a collaborator, "Cancer and Leukemia Group B" with 6 trials as a collaborator, "SWOG Cancer Research Network" with 4 trials as a collaborator, "NRG Oncology" with 3 trials as a collaborator and "North Central Cancer Treatment Group" with 3 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Salem Hospital Regional Cancer Care Services" are "Breast Cancer" (7 trials), "Lung Cancer" (4 trials), "Esophageal Cancer" (3 trials), "Colorectal Cancer" (2 trials) and "Lymphoma" (2 trials). Many other conditions were trialed in "Salem Hospital Regional Cancer Care Services" in a lesser frequency.

Most popular intervention types in "Salem Hospital Regional Cancer Care Services" are "Drug" (21 trials), "Radiation" (9 trials), "Other" (8 trials), "Biological" (7 trials) and "Dietary Supplement" (2 trials). Other intervention types were less common.

The name of intervention was led by "cisplatin" (6 trials), "cetuximab" (4 trials), "radiation therapy" (4 trials), "fluorouracil" (3 trials) and "paclitaxel" (3 trials). Other intervention names were less common.

The vast majority of trials in "Salem Hospital Regional Cancer Care Services" are 20 trials for "All" genders, 7 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Salem Hospital Regional Cancer Care Services". undefined are not yet recruiting, undefined are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 24 completed trials in Salem Hospital Regional Cancer Care Services, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Salem Hospital Regional Cancer Care Services, 0 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 17 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".